Imatinib enhances functional outcome after spinal cord injury
about
Rat models of spinal cord injury: from pathology to potential therapiesDrug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injuryPharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disordersPresymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.Improved recovery from spinal cord injury in rats with chronic parvovirus serotype-1a infection.Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune responseSpatial and cellular characterization of mTORC1 activation after spinal cord injury reveals biphasic increase mainly attributed to microglia/macrophages.Imatinib treatment reduces brain injury in a murine model of traumatic brain injuryDelayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum BiomarkersRat substrains differ in the magnitude of spontaneous locomotor recovery and in the development of mechanical hypersensitivity after experimental spinal cord injury.Longitudinal assessment of imatinib's effect on the blood-brain barrier after ischemia/reperfusion injury with permeability MRI.Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury.Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.Repositioning imatinib for spinal cord injury.Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment.Regenerative Strategies for the Central Nervous System
P2860
Q28071816-EDEB3BF7-49D0-454A-BCA6-BBAC0B2E291FQ28085174-3A2450B6-A82F-4491-92A8-CF99F55BFD66Q29048615-608D02AB-E63B-4941-AFBA-2C0995063FD9Q30746065-D79C9A0E-9DFF-403F-BC56-F463ED9B9561Q33586717-293C7CD8-8D73-4862-841D-47153D69A3A4Q34352802-450942A2-D6AD-449D-B5D3-C43F571C290AQ34599027-F89C84FE-759C-4890-B8FD-CD119511C0D1Q35140800-0F0F93AD-C8D3-4F8C-94FC-A8A276F79C3CQ36129940-765B5C57-0F73-42FF-9B74-BD13770592A3Q36576063-74D31585-3E5E-4083-99E8-EBE0183D6939Q37244603-7074E464-E842-49D6-86A5-88378C3E9933Q39141643-CE6B4308-5598-4FCB-95A9-B5CA6D7AD518Q39415268-F20953D3-13C6-414E-B906-2410F0754B08Q41581073-9288BC23-49F5-489D-A06F-DD92ABA3EFFCQ41634845-DA9AC782-D1B3-4028-BC76-B75280428D0DQ43154350-870AB282-EA76-4714-8F7F-D3073EEF72CEQ50437657-0085ADC0-5004-46F8-BE36-02EA49C39156Q57460363-C4A7DAEA-659F-4945-8423-D4AA669B3B7A
P2860
Imatinib enhances functional outcome after spinal cord injury
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Imatinib enhances functional outcome after spinal cord injury
@ast
Imatinib enhances functional outcome after spinal cord injury
@en
Imatinib enhances functional outcome after spinal cord injury
@nl
type
label
Imatinib enhances functional outcome after spinal cord injury
@ast
Imatinib enhances functional outcome after spinal cord injury
@en
Imatinib enhances functional outcome after spinal cord injury
@nl
prefLabel
Imatinib enhances functional outcome after spinal cord injury
@ast
Imatinib enhances functional outcome after spinal cord injury
@en
Imatinib enhances functional outcome after spinal cord injury
@nl
P2093
P2860
P50
P3181
P1433
P1476
Imatinib enhances functional outcome after spinal cord injury
@en
P2093
Ingrid Nilsson
Lars Olson
Mathew B Abrams
Ulf Eriksson
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0038760
P407
P577
2012-01-01T00:00:00Z